Breeze Acquisition Corp. II quarterly report, Q1 FY2026

Breeze Acquisition Corp. II — Form 10-Q Summary

Reporting period: Three months ended March 31, 2026. The financial statements are unaudited. The filing was signed September 23, 2026, and includes material subsequent events through August 20, 2026.

Business context

Breeze Acquisition Corp. II is a Cayman Islands blank check company formed on August 20, 2025 to pursue a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. As of March 31, 2026, it had not commenced operations, selected a target, or initiated substantive discussions with a target. It is a shell company, smaller reporting company and emerging growth company.

The initial public offering closed after the quarter, on May 14, 2026. The company sold 12.5 million units for gross proceeds of $125.0 million and sold 447,500 private placement units for $4.475 million. On May 15, 2026, the underwriter exercised part of its over-allotment option, adding 1.5 million public units for $15.0 million, and the sponsor purchased 22,500 additional private placement units for $225,000.

Financial condition and results

MetricMarch 31, 2026December 31, 2025
Total assets$491,200$217,168
Prepaid expenses$37,137$39,678
Deferred offering costs$454,063$177,490
Total liabilities$730,745$318,507
Related-party promissory note$427,150$162,650
Accounts payable$289,166$85,412
Accumulated deficit$(264,545)$(126,339)
Shareholders’ deficit$(239,545)$(101,339)

The company reported no revenue and a net loss of $138,206 for the quarter, consisting entirely of operating and formation costs. Basic and diluted loss per share was $0.03 based on 4,391,892 weighted-average shares. No margin measure is meaningful because the company has not generated operating revenue.

Net cash used in operating activities was $133,239. Financing activities provided $133,239, consisting of $264,500 of related-party promissory-note proceeds, partially offset by $131,261 of deferred offering-cost payments. Net change in cash was zero; the company reported no cash or cash equivalents at March 31, 2026.

Working capital was negative $693,608 at March 31, 2026. The company had no bank debt or working-capital loans outstanding, but the related-party promissory note was payable upon the earlier of December 31, 2026 or completion of the IPO. It was repaid in full on May 14, 2026.

Material changes and subsequent events

  • Total assets increased $274,032 from December 31, 2025, primarily because of higher deferred offering costs.
  • Total liabilities increased $412,238, driven primarily by the related-party promissory note and accounts payable.
  • Accumulated deficit increased by the quarterly net loss of $138,206.
  • The IPO and private placement generated aggregate gross proceeds of $129.475 million before the over-allotment exercise. The subsequent exercise and additional private placement generated another $15.225 million.
  • The filing reports differing trust-account amounts in various sections: $125.59375 million in the notes, $125.3125 million in MD&A after the IPO, and $140.350 million in the later securities-use-of-proceeds disclosure after the over-allotment exercise. The exact final trust balance should be verified against the applicable Form 8-K and prospectus.
  • Following the partial over-allotment exercise, 131,757 founder shares were forfeited and 527,027 founder shares were released from forfeiture.

Outlook, risks and unusual items

The company must complete an initial business combination by May 14, 2027, unless the period is extended through the required shareholder process. If it does not complete a transaction by that date, it must liquidate and redeem public shares using the trust-account funds, subject to applicable requirements. Rights would expire worthless in a liquidation.

Management states that substantially all trust-account proceeds are intended for a business combination. The company may need additional financing if transaction costs exceed estimates, significant shareholder redemptions occur, or additional capital is required to complete a transaction.

Management concluded that conditions existing before the IPO raised substantial doubt about the company’s ability to continue as a going concern for one year after issuance of the financial statements. The financial statements contain no adjustments for a possible liquidation. Management also states that no target has been selected and there is no assurance that a business combination will be completed.

Disclosure controls and procedures were ineffective because of a material weakness in internal control over financial reporting. The weakness related to inadequate review of vendor service contracts, which resulted in recording an obligation that did not exist and disbursing cash under that obligation. Management is implementing additional contract-review procedures.

On August 20, 2026, Nasdaq notified the company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) because its March 31 and June 30, 2026 Forms 10-Q were delinquent. The company submitted a compliance plan on September 18, 2026. The notice had no immediate effect on trading, but Nasdaq may grant an exception through December 28, 2026, subject to its review.

Other risks include failure to identify or complete a suitable transaction, market and geopolitical volatility, potential dilution from founder shares, private units and rights, redemption pressure, reliance on the sponsor for financing, and possible liquidation if the completion deadline is missed.

Investor verification checklist

  • Verify the final IPO, over-allotment, private-placement proceeds and trust-account balance using the related Form 8-K and prospectus.
  • Confirm the company’s Nasdaq compliance status, including acceptance of its compliance plan and any subsequent delisting or extension notices.
  • Assess the material weakness, the vendor-contract error, and the status and effectiveness of remediation.
  • Review the May 14, 2026 IPO closing and May 15, 2026 over-allotment disclosures for consistency with the March 31 balance-sheet presentation.
  • Confirm the May 14, 2027 business-combination deadline and the terms governing any shareholder-approved extension.
  • Evaluate dilution and lock-up terms for founder shares, private units, rights, representative shares and potential working-capital-unit conversions.
  • Note the filing’s reported cover-page share count as of September 23, 2026 and reconcile it to post-IPO shares outstanding and forfeitures.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.